In Collaboration with Glatt Systems
Date: November 12th
Time: 11 AM to 12:30 PM (CET)
Description: The global vaccine landscape is evolving rapidly, driven by the need for affordability, scalability, and sustainability. This session explores how engineered bioprocess solutions can transform vaccine manufacturing – making it more efficient, compliant, and future-ready.
What You’ll Learn:
- Global vaccine market trends and emerging challenges for manufacturers.
- How to overcome cost and compliance pressures through engineered solutions.
- The role of technology — automation, modular design in building flexible, scalable vaccine facilities.
- Real-world case studies demonstrate cost optimization and faster time-to-market.
- Future outlook: digital transformation, AI, and next-gen vaccine platforms.
Key Takeaways:
- A clear roadmap for developing a sustainable vaccine ecosystem.
- Practical insights on reducing COGS while maintaining regulatory compliance.
- Understanding how integrated engineering drives quality, speed, and efficiency.
- Strategies to build long-term competitiveness in global vaccine supply.
Who Should Attend:
- Vaccine and biopharma manufacturers
- Process and project engineers
- R&D and production leaders
- Quality and regulatory professionals
Decision-makers exploring facility expansion or modernization
Speaker: Mr. Bhimasen Vadavi, Chief technical officer (CTO), Glatt Bioprocess solutions
Biography: Mr. Bhimasen is an accomplished engineer and business leader with over 25 years of international experience in bioprocess equipment automation and project execution. He has led numerous high-profile projects worldwide, demonstrating expertise in designing and implementing advanced biotech solutions. Recognized for his technical insight and leadership, he has contributed significantly to the development of efficient systems and innovative processes within the biopharmaceutical industry.
Known for his technical acumen and strategic leadership, Mr. Bhimasen has consistently delivered innovative and efficient systems that address the complexities of the biopharmaceutical industry, contributing significantly to the advancement of cutting-edge technologies and processes.
